(PharmaNewsWire.Com, January 26, 2018 ) The Immunotherapy Drugs Market accounted to USD 107 billion in 2016 growing at a CAGR of 13.2% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Immunotherapy drugs are used to treat cancer, infection, respiratory and autoimmune disorders. Immunotherapies either stimulate the activities done by specific components of the immune system or counteract the signals that are produced by the cancer cells and suppress the immune responses.
Increase in the prevalence of cancer and a number of autoimmune diseases
Rising need for mAbs
Increasing demand of biological and targeted drug therapies
Technological developments
High cost of drug development
Market Segmentation: Immunotherapy Drugs Market
By Type of Drugsthe market for Immunotherapy drugs is segmented into Adult Vaccines, Checkpoint Inhibitors, and Interferons Alpha.
By Therapyarea the Immunotherapy drugs market is segmented into Cancer, Autoimmune Diseases, and Infectious Diseases.
On the basis of end-users the Immunotherapy drugs market is segmented into hospitals.
On the basis of geography, Immunotherapy drugs market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.
The Global Immunotherapy drugs market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Immunotherapy drugs market for global, Europe, North America, Asia Pacific and South America.
Major Market Competitors: Immunotherapy Drugs Market
Some of the major players operating in Immunotherapy drugs market are Amgen Inc., Johnson & Johnson, Abbvie, Glaxo Smith Kline,Amgen Inc., Eli lilly& Co.,Astrazeneca, Roche diagnostics, Novartis AG,Bristol-Myers Squibb, Pfizer, ELI Lilly and Company, Merck & Co., Sanofi, and Celgene Corporation. Roche, Novartis and Celgene among others
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
